Zacks Research Issues Negative Forecast for MTD Earnings

Mettler-Toledo International Inc. (NYSE:MTD) – Equities research analysts at Zacks Research cut their Q1 2025 EPS estimates for Mettler-Toledo International in a note issued to investors on Monday, January 6th. Zacks Research analyst R. Department now anticipates that the medical instruments supplier will post earnings per share of $8.42 for the quarter, down from their previous estimate of $8.78. The consensus estimate for Mettler-Toledo International’s current full-year earnings is $40.42 per share. Zacks Research also issued estimates for Mettler-Toledo International’s Q2 2025 earnings at $10.25 EPS, FY2025 earnings at $41.94 EPS, Q1 2026 earnings at $9.97 EPS, Q2 2026 earnings at $11.03 EPS and FY2026 earnings at $48.62 EPS.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The company had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million.

Several other equities research analysts have also issued reports on MTD. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and lifted their price target for the company from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Evercore ISI upgraded shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and lifted their target price for the company from $1,375.00 to $1,450.00 in a research note on Thursday, January 2nd. Stifel Nicolaus dropped their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Wolfe Research started coverage on shares of Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating on the stock. Finally, Robert W. Baird decreased their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $1,351.25.

Mettler-Toledo International Trading Down 0.8 %

MTD opened at $1,245.45 on Wednesday. Mettler-Toledo International has a 1 year low of $1,122.21 and a 1 year high of $1,546.93. The stock has a fifty day moving average price of $1,253.23 and a 200 day moving average price of $1,350.06. The stock has a market cap of $26.28 billion, a price-to-earnings ratio of 33.58, a PEG ratio of 4.21 and a beta of 1.12.

Insider Buying and Selling

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the sale, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. This trade represents a 95.89 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now owns 240 shares of the company’s stock, valued at approximately $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. JPMorgan Chase & Co. grew its position in Mettler-Toledo International by 14.7% during the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after buying an additional 28,478 shares in the last quarter. Allspring Global Investments Holdings LLC grew its holdings in shares of Mettler-Toledo International by 14.0% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,240 shares of the medical instruments supplier’s stock worth $1,860,000 after purchasing an additional 152 shares in the last quarter. Quest Partners LLC increased its position in shares of Mettler-Toledo International by 878.1% during the third quarter. Quest Partners LLC now owns 1,027 shares of the medical instruments supplier’s stock valued at $1,540,000 after purchasing an additional 922 shares during the period. Federated Hermes Inc. raised its stake in shares of Mettler-Toledo International by 10.3% in the second quarter. Federated Hermes Inc. now owns 7,667 shares of the medical instruments supplier’s stock valued at $10,715,000 after purchasing an additional 717 shares in the last quarter. Finally, M&T Bank Corp lifted its position in Mettler-Toledo International by 14.3% in the third quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier’s stock worth $7,387,000 after purchasing an additional 615 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.